TMC Life Sciences, Going Places In A Crowded Market
Nadiah Wan, Executive Director & Group Chief Executive Officer, TMC Life Sciences
07-Apr-23 08:00
Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
Private Healthcare providers saw earnings decline sharply during the pandemic as most differed elective procedures. But is recovery in sight? Nadiah Wan, Group CEO of listed TMC Life Sciences Bhd gives us that answer whilst offering her views on the structural issues facing Malaysia's healthcare system and if public private partnerships are one solution.
Produced by: Moh Heng Ying
Presented by: Wong Shou Ning
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: Corporates, health policy
Tags: thomson hospital, healthcare reform, healthcare costs, tmc life sciences, public-private partnership,
